Continuous bioprocessing: A ‘life changing’ method, says NIBRT

By Flora Southey contact

- Last updated on GMT

NIBRT is embracing continuous bioprocessing says training director John Milne, who told us the method helps improve plant flexibility and could reduce manufacturing costs.

On a site visit last month at Ireland’s National Institute for Bioprocessing Research and Technology (NIBRT) in Dublin, Milne told Biopharma-Reporter the continuous method – as opposed to batch – is attracting increased interest in the biologics space.

“In the small molecule industry for example, people have been applying these strategies.

“Biologics has taken a longer time to be convinced,” ​said Milne, but added he has observed a lot of activity in continuous manufacturing, and will “definitely see more.”

“It is going to change our lives in a very positive way going forward.”

Speaking to delegates at the Biopharma Ambition Conference – also in Dublin – CEO Dominic Carolan said the bioprocessing method has not been taken onboard by all firms.

“Some companies are certainly looking at it closely, some companies have decided perhaps it’s not for them at this point.

“The technologies need to be developed, because this has huge potential of course for reducing cost in the future,” ​he added.

Continuous bioprocessing training is gaining traction, as demonstrated by Pall Life Sciences announcement​ last year to equip a Swiss training facility in order to theoretical and practical training in the continuous method to biomanufacturers.

Related news

Show more

Related products

show more

Accelerating Time to IND with Pharma 4.0

Accelerating Time to IND with Pharma 4.0

Wheeler Bio | 22-Sep-2022 | Technical / White Paper

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation.

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Related suppliers

Follow us

Products

View more

Webinars